Home » Genzyme Recalls Three Lots of Transplant Drug, FDA Says
Genzyme Recalls Three Lots of Transplant Drug, FDA Says
Genzyme Corp. voluntarily recalled three lots of Thymoglobulin, a drug used during transplants, after the solution was found to have a different appearance than usual, the Food and Drug Administration said on its website.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May